SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...
Labviva has launched its automated inventory management system (IMS) to enable laboratory scientists, researchers, and procurement professionals to work in real time by streamlining inventory ...